• Cardinal Health (Dublin, Ohio) has launched a new system that leverages its dispensing technologies to enable clinicians access to a patient's medications and medical supplies from one system. The Pyxis DuoStation system helps clinicians to safely and accurately dispense both medications and medical supplies from a single dispensing machine. Nurses use unique identifiers, such as an employee ID number and their fingerprint, to log onto the system. After log-in, a screen appears and the nurse selects a patient and sees a list of medication orders that have already been verified by one of the hospital pharmacists. Additionally, the nurse can toggle to a medical supplies screen and select the supplies needed to care for the patient. In addition to the safety benefits of dispensing the right medications for the right patient, the system records the medications and supplies used for each patient and then transfers the information to the hospital's billing system.

• GlycoMark (New York) reported results from the ongoing DURABLE clinical trial showing that the GlycoMark blood test is a better reflection of glucose, particularly after-meal glucose levels, than the gold standard hemoglobin A1C test in moderately controlled patients with diabetes. GlycoMark is an FDA-approved test for monitoring intermediate glycemic control by measuring the levels of a monosaccharide 1,5-anhydroglucitol (1,5- AG) in blood. GlycoMark is being used in clinical practices nationwide and is available at major reference laboratories.